FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study

Ashish Sharma, Luke Nicholson, Clara Vazquez-Alfageme, Vasuki Sivagnanavel, Riccardo Fausto, Maria Cristina Soare, Marta Bautista Salamanca, Lorenzo Fabozzi, Chrysanthi Tsika, Olga Cejudo Corbalan, Alejandro Gomez Verdejo, Taku Wakabayashi, Se Joon Woo, Anton M. Kolomeyer, Hana Mansour, Bita Momenaei, Carl D. Regillo, Unknown, Baruch D. Kuppermann, Anat Loewenstein, Francesco Bandello, Giuseppe Querques, Tomoko Ueda-Consolvo, Masaaki Ishida, Tomoko Nakamura, Shuichiro Yanagisawa, Atsushi Hayashi, Kotaro Tsuboi, Nilesh Kumar, Nikulaa Parachuri, Jay Sheth, Seemantini Ayachit, Chitaranjan Mishra, Debdulal Chakraborty, Alay Banker, Kourous A. Rezaei, Arshad M. Khanani, Peter K. Kaiser, Frank G. Holz, Sobha Sivaprasad, Şengül Özdek, Kodjikian Laurent, Alper Bilgic, Paolo Lanzetta, Valentina Sarao, Caroline Baumal, Nancy Holekemp, Taiji Sakamoto, Adnan Tufail, Nicolas Yannuzzi, Jayanth Sridhar, Giulia Corradetti, Assaf Hilely, David Boyer, Aleksandra Rachitskaya, Tunde Peto, Maximilian W. M. Wintergerst, Barbara Parolini, Prithvi Mruthyunjaya, Quan Dong Nguyen, Diana V. DO, Pearse A. Keane, Tarek Hassan, David Eichenbaum, Dilraj S. Grewal, Francesc March, Martin S. Spitzer, Khalil G. Falavarjani, Martin S. Zinkernagel, Christopher Seungkyu Lee, Judy E. Kim

Open source

DOI: 10.1038/s41433-025-04030-7
Published: 2025-10-02
Container: Eye
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41433-025-04030-7,
title = {FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study},
author = {Ashish Sharma and Luke Nicholson and Clara Vazquez-Alfageme and Vasuki Sivagnanavel and Riccardo Fausto and Maria Cristina Soare and Marta Bautista Salamanca and Lorenzo Fabozzi and Chrysanthi Tsika and Olga Cejudo Corbalan and Alejandro Gomez Verdejo and Taku Wakabayashi and Se Joon Woo and Anton M. Kolomeyer and Hana Mansour and Bita Momenaei and Carl D. Regillo and Unknown and Baruch D. Kuppermann and Anat Loewenstein and Francesco Bandello and Giuseppe Querques and Tomoko Ueda-Consolvo and Masaaki Ishida and Tomoko Nakamura and Shuichiro Yanagisawa and Atsushi Hayashi and Kotaro Tsuboi and Nilesh Kumar and Nikulaa Parachuri and Jay Sheth and Seemantini Ayachit and Chitaranjan Mishra and Debdulal Chakraborty and Alay Banker and Kourous A. Rezaei and Arshad M. Khanani and Peter K. Kaiser and Frank G. Holz and Sobha Sivaprasad and Şengül Özdek and Kodjikian Laurent and Alper Bilgic and Paolo Lanzetta and Valentina Sarao and Caroline Baumal and Nancy Holekemp and Taiji Sakamoto and Adnan Tufail and Nicolas Yannuzzi and Jayanth Sridhar and Giulia Corradetti and Assaf Hilely and David Boyer and Aleksandra Rachitskaya and Tunde Peto and Maximilian W. M. Wintergerst and Barbara Parolini and Prithvi Mruthyunjaya and Quan Dong Nguyen and Diana V. DO and Pearse A. Keane and Tarek Hassan and David Eichenbaum and Dilraj S. Grewal and Francesc March and Martin S. Spitzer and Khalil G. Falavarjani and Martin S. Zinkernagel and Christopher Seungkyu Lee and Judy E. Kim},
year = {2025},
journal = {Eye},
doi = {10.1038/s41433-025-04030-7},
url = {https://doi.org/10.1038/s41433-025-04030-7}
}

RIS

TY  - JOUR
TI  - FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study
AU  - Ashish Sharma
AU  - Luke Nicholson
AU  - Clara Vazquez-Alfageme
AU  - Vasuki Sivagnanavel
AU  - Riccardo Fausto
AU  - Maria Cristina Soare
AU  - Marta Bautista Salamanca
AU  - Lorenzo Fabozzi
AU  - Chrysanthi Tsika
AU  - Olga Cejudo Corbalan
AU  - Alejandro Gomez Verdejo
AU  - Taku Wakabayashi
AU  - Se Joon Woo
AU  - Anton M. Kolomeyer
AU  - Hana Mansour
AU  - Bita Momenaei
AU  - Carl D. Regillo
AU  - Unknown
AU  - Baruch D. Kuppermann
AU  - Anat Loewenstein
AU  - Francesco Bandello
AU  - Giuseppe Querques
AU  - Tomoko Ueda-Consolvo
AU  - Masaaki Ishida
AU  - Tomoko Nakamura
AU  - Shuichiro Yanagisawa
AU  - Atsushi Hayashi
AU  - Kotaro Tsuboi
AU  - Nilesh Kumar
AU  - Nikulaa Parachuri
AU  - Jay Sheth
AU  - Seemantini Ayachit
AU  - Chitaranjan Mishra
AU  - Debdulal Chakraborty
AU  - Alay Banker
AU  - Kourous A. Rezaei
AU  - Arshad M. Khanani
AU  - Peter K. Kaiser
AU  - Frank G. Holz
AU  - Sobha Sivaprasad
AU  - Şengül Özdek
AU  - Kodjikian Laurent
AU  - Alper Bilgic
AU  - Paolo Lanzetta
AU  - Valentina Sarao
AU  - Caroline Baumal
AU  - Nancy Holekemp
AU  - Taiji Sakamoto
AU  - Adnan Tufail
AU  - Nicolas Yannuzzi
AU  - Jayanth Sridhar
AU  - Giulia Corradetti
AU  - Assaf Hilely
AU  - David Boyer
AU  - Aleksandra Rachitskaya
AU  - Tunde Peto
AU  - Maximilian W. M. Wintergerst
AU  - Barbara Parolini
AU  - Prithvi Mruthyunjaya
AU  - Quan Dong Nguyen
AU  - Diana V. DO
AU  - Pearse A. Keane
AU  - Tarek Hassan
AU  - David Eichenbaum
AU  - Dilraj S. Grewal
AU  - Francesc March
AU  - Martin S. Spitzer
AU  - Khalil G. Falavarjani
AU  - Martin S. Zinkernagel
AU  - Christopher Seungkyu Lee
AU  - Judy E. Kim
PY  - 2025
JO  - Eye
DO  - 10.1038/s41433-025-04030-7
UR  - https://doi.org/10.1038/s41433-025-04030-7
ER  -

APA

Sharma, A., Nicholson, L., Vazquez-Alfageme, C., Sivagnanavel, V., Fausto, R., Soare, M. C., Salamanca, M. B., Fabozzi, L., Tsika, C., Corbalan, O. C., Verdejo, A. G., Wakabayashi, T., Woo, S. J., Kolomeyer, A. M., Mansour, H., Momenaei, B., Regillo, C. D., Unknown, Kuppermann, B. D., Loewenstein, A., Bandello, F., Querques, G., Ueda-Consolvo, T., Ishida, M., Nakamura, T., Yanagisawa, S., Hayashi, A., Tsuboi, K., Kumar, N., Parachuri, N., Sheth, J., Ayachit, S., Mishra, C., Chakraborty, D., Banker, A., Rezaei, K. A., Khanani, A. M., Kaiser, P. K., Holz, F. G., Sivaprasad, S., Özdek, Ş., Laurent, K., Bilgic, A., Lanzetta, P., Sarao, V., Baumal, C., Holekemp, N., Sakamoto, T., Tufail, A., Yannuzzi, N., Sridhar, J., Corradetti, G., Hilely, A., Boyer, D., Rachitskaya, A., Peto, T., Wintergerst, M. W. M., Parolini, B., Mruthyunjaya, P., Nguyen, Q. D., DO, D. V., Keane, P. A., Hassan, T., Eichenbaum, D., Grewal, D. S., March, F., Spitzer, M. S., Falavarjani, K. G., Zinkernagel, M. S., Lee, C. S., & Kim, J. E. (2025). FYB-201 Biosimilar ranibizumab (Ongavia/Ranivisio/Cimerli) Efficacy and Safety in Clinical Settings – FORCE study. Eye. https://doi.org/10.1038/s41433-025-04030-7

Source records

crossref · retrieved 2026-09-26T14:56:06.279Z